-
UL Helps Advance Vaccination Storage Technologies with New World Health Organization Accreditation
prnasia
July 14, 2020
UL, a leading global safety science company, has announced that its Refrigeration Laboratory in Gurugram, India, has received World Health Organization (WHO) accreditation as a designated third-party testing laboratory for refrigeration equipment used for
-
WHO reviewing report urging new guidance over airborne spread of coronavirus
expresspharma
July 08, 2020
How frequently the coronavirus can spread by the airborne or aerosol route - as opposed to by larger droplets in coughs and sneezes - is not clear.
-
Hundreds of scientists say coronavirus is airborne, ask WHO to revise recommendations: NYT
expresspharma
July 07, 2020
The WHO has said the coronavirus disease spreads primarily from person to person through small droplets from the nose or mouth.
-
WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death
expresspharma
July 07, 2020
The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day.
-
WHO to discontinue hydroxycholorquine trial for COVID-19
expresspharma
July 06, 2020
It said interim results show hydroxychloroquine “produce little or no reduction in the mortality of hospitalised COVID-19 patients when compared to standard of care.”
-
Emer Cooke nominated as new EMA Executive Director
expresspharma
June 28, 2020
Emer Cooke is currently the Director of the Regulation and Prequalification Department at the World Health Organization (WHO) in Geneva.
-
WHO moves to update COVID-19 guidance after ‘great news’ in dexamethasone study
expresspharma
June 18, 2020
Trial results announced showed dexamethasone, used since the 1960s to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill COVID-19 patients admitted to hospital.
-
WHO stresses need for new treatments to reduce antimicrobial resistance
europeanpharmaceuticalreview
June 15, 2020
Following a record level of data collated by WHO, the organisation has emphasised that new antibiotics need to be developed to tackle the rise of global antimicrobial resistance.
-
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns
expresspharma
May 26, 2020
Dr Mike Ryan, head of the WHO emergencies programme, said the decision to suspend trials of hydroxychloroquine had been taken out of “an abundance of caution”.
-
NICE joins international COVID-19 pandemic response
pharmatimes
May 07, 2020
The National Institute for Health and Care Excellence (NICE) says it is supporting a growing number of international collaborations striving to share knowledge and identify new treatments in response to the COVID-19 pandemic.